CRON vs USNA
Cronos Group Inc. and Usana Health Sciences Inc., side by side — 9 fiscal years reported in USD, drawn from SEC filings.
Most recent reported year
| Metric | CRON | USNA |
|---|---|---|
| Revenue | $193.4M | $925.3M |
| Net income | $-9.4M | $10.8M |
| Gross margin | 42.8% | 78.3% |
| Net margin | −2.0% | 1.2% |
| Return on equity | −0.9% | 2.0% |
| Diluted EPS | −$0.02 | $0.58 |
| Dividend / share | · | · |
| Payout ratio | · | · |
| Free cash flow | $149,000 | $8.5M |
| Equity | $1.1B | $533.1M |
| Net debt / equity | · | · |
| Current ratio | 19.59× | 2.24× |
| Revenue CAGR 5y | 28.9% | −4.0% |
| Profit CAGR 5y | · | −38.7% |
USNA bills 4.8× the revenue of CRON, and CRON closed the last reported year at a loss.
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner. "·" marks a figure not available in our data.
9 years side by side
| Fiscal year | CRON | USNA |
|---|---|---|
| FY2025 | $193.4M | $925.3M |
| FY2024 | $161.8M | $854.5M |
| FY2023 | $120.3M | $921.0M |
| FY2022 | $109.3M | $998.6M |
| FY2021 | $79.6M | $1.2B |
| FY2020 | $54.4M | $1.1B |
| FY2019 | $25.6M | $1.1B |
| FY2018 | $13.2M | $1.2B |
| FY2017 | $3.1M | $1.0B |
Bottom line
| Fiscal year | CRON | USNA |
|---|---|---|
| FY2025 | $-9.4M | $10.8M |
| FY2024 | $41.1M | $42.0M |
| FY2023 | $-74.0M | $63.8M |
| FY2022 | $-168.7M | $69.3M |
| FY2021 | $-396.1M | $116.5M |
| FY2020 | $-73.1M | $124.7M |
| FY2019 | $1.2B | $100.5M |
| FY2018 | $-21.6M | $126.2M |
| FY2017 | $-1.5M | $62.5M |
9 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | −$731,894,000 | USNA |
| FY2024 | −$692,682,000 | USNA |
| FY2023 | −$800,740,000 | USNA |
| FY2022 | −$889,300,000 | USNA |
| FY2021 | −$1,106,852,000 | USNA |
| FY2020 | −$1,080,291,000 | USNA |
| FY2019 | −$1,035,263,000 | USNA |
| FY2018 | −$1,176,014,000 | USNA |
| FY2017 | −$1,044,118,000 | USNA |
USNA has reported the higher revenue in every one of these 9 fiscal years. The gap has narrowed since the earliest year compared.
9 of 17 comparable fiscal years — a year missing data on either side is not counted.
8 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | −3.2 pp | USNA |
| FY2024 | +29.1 pp | CRON |
| FY2023 | −92.4 pp | USNA |
| FY2022 | −201.5 pp | USNA |
| FY2021 | −625.1 pp | USNA |
| FY2020 | −172.1 pp | USNA |
| FY2018 | −190.6 pp | USNA |
| FY2017 | −53.1 pp | USNA |
The higher net margin has changed hands between CRON and USNA over this period.
8 of 17 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
CRON's net margin has been more volatile than USNA's over the 8 comparable fiscal years — 190.3 percentage points of standard deviation against 3.1.
8 of 17 comparable fiscal years — a year missing data on either side is not counted.
Year by year
The lead in net margin changed hands between CRON and USNA over these 8 fiscal years — CRON led in 1 and USNA in 7.
8 of 17 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
CRON's return on equity has been more volatile than USNA's over the 9 comparable fiscal years — 42.4 percentage points of standard deviation against 10.2.
9 of 17 comparable fiscal years — a year missing data on either side is not counted.
Year by year
The lead in return on equity changed hands between CRON and USNA over these 9 fiscal years — CRON led in 1 and USNA in 8.
9 of 17 comparable fiscal years — a year missing data on either side is not counted.